Personalis, Inc. Retained Earnings
Personalis, Inc. (PSNL) had Retained Earnings of -$692.98 million as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-08-04
- 2026-06-30: Retained Earnings (Accumulated Deficit) -$692.98M.
- 2026-03-31: Retained Earnings (Accumulated Deficit) -$661.29M.
- 2025-12-31: Retained Earnings (Accumulated Deficit) -$631.26M.
- 2025-09-30: Retained Earnings (Accumulated Deficit) -$607.45M.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2026-06-30 | -$692.98M 10-Q · filed 2026-08-04 |
| 2026-03-31 | -$661.29M 10-Q · filed 2026-05-07 |
| 2025-12-31 | -$631.26M 10-Q · filed 2026-08-04 |
| 2025-09-30 | -$607.45M 10-Q · filed 2025-11-04 |
| 2025-06-30 | -$585.80M 10-Q · filed 2025-08-05 |
| 2025-03-31 | -$565.74M 10-Q · filed 2025-05-06 |
| 2024-12-31 | -$549.99M 10-K · filed 2026-02-26 |
| 2024-09-30 | -$533.57M 10-Q · filed 2024-11-06 |
| 2024-06-30 | -$494.48M 10-Q · filed 2024-08-07 |
| 2024-03-31 | -$481.67M 10-Q · filed 2024-05-08 |
| 2023-12-31 | -$468.71M 10-K · filed 2025-02-27 |
| 2023-09-30 | -$442.12M 10-Q · filed 2023-11-07 |
| 2023-06-30 | -$413.02M 10-Q · filed 2023-08-08 |
| 2023-03-31 | -$389.07M 10-Q · filed 2023-05-03 |
| 2022-12-31 | -$360.41M 10-K · filed 2024-02-28 |
| 2022-09-30 | -$329.34M 10-Q · filed 2022-11-02 |
| 2022-06-30 | -$302.85M 10-Q · filed 2022-08-03 |
| 2022-03-31 | -$275.30M 10-Q · filed 2022-05-04 |
| 2021-12-31 | -$247.09M 10-K · filed 2023-02-23 |
| 2021-09-30 | -$226.90M 10-Q · filed 2021-11-04 |
| 2021-06-30 | -$209.23M 10-Q · filed 2021-08-04 |
| 2021-03-31 | -$194.27M 10-Q · filed 2021-05-05 |
| 2020-12-31 | -$181.87M 10-K · filed 2022-02-24 |
| 2020-09-30 | -$168.53M 10-Q · filed 2020-11-05 |
| 2020-06-30 | -$158.98M 10-Q · filed 2020-08-06 |
| 2020-03-31 | -$149.73M 10-Q · filed 2020-05-07 |
| 2019-12-31 | -$140.59M 10-K · filed 2021-02-25 |
| 2019-09-30 | -$133.94M 10-Q · filed 2019-11-13 |
| 2019-06-30 | -$127.06M 10-Q · filed 2019-08-13 |
| 2018-12-31 | -$115.50M 10-K · filed 2020-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |